Literature DB >> 1370559

Mutations within the proteolytic cleavage site of the Rous sarcoma virus glycoprotein define a requirement for dibasic residues for intracellular cleavage.

J Y Dong1, J W Dubay, L G Perez, E Hunter.   

Abstract

We investigated the amino acid sequence requirements for intracellular cleavage of the Rous sarcoma virus glycoprotein precursor by introducing mutations into the region encoding the cleavage recognition site (Arg-Arg-Lys-Arg). In addition to mutants G1 (Arg-Arg-Glu-Arg) and Dr1 (deletion of all four codons) that we have reported on previously (L. G. Perez and E. Hunter, J. Virol. 61:1609-1614, 1987), we constructed two additional mutants, AR1 (Arg-Arg-Arg-Arg), in which the highly conserved lysine is replaced by an arginine, and S19 (Ser-Arg-Glu-Arg), in which no dibasic pairs remain. The results of these studies demonstrate that when the cleavage sequence is deleted (Dr1) or modified to contain unpaired basic residues (S19), intracellular cleavage of the glycoprotein precursor is completely blocked. This demonstrates that the cellular endopeptidase responsible for cleavage has a stringent requirement for the presence of a pair of basic residues (Arg-Arg or Lys-Arg). Furthermore, it implies that the cleavage enzyme is not trypsinlike, since it is unable to recognize arginine residues that are sensitive to trypsin action. Substitution of the mutated genes into a replication-competent avian retrovirus genome showed that cleavage of the glycoprotein precursor was not required for incorporation into virions but was necessary for infectivity. Treatment of BH-RCAN-S19-transfected turkey cells with low levels of trypsin resulted in the release of infectious virus, demonstrating that exogenous cleavage could generate a biologically active glycoprotein molecule.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1370559      PMCID: PMC240787     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Oligomeric structure of a prototype retrovirus glycoprotein.

Authors:  D Einfeld; E Hunter
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

2.  Mutations at the cleavage site of the hemagglutinin after the pathogenicity of influenza virus A/chick/Penn/83 (H5N2).

Authors:  M Ohuchi; M Orlich; R Ohuchi; B E Simpson; W Garten; H D Klenk; R Rott
Journal:  Virology       Date:  1989-02       Impact factor: 3.616

3.  Synthesis and processing of viral glycoproteins in two nonconditional mutants of Rous sarcoma virus.

Authors:  M Linial; J Fenno; W N Burnette; L Rohrschneider
Journal:  J Virol       Date:  1980-10       Impact factor: 5.103

4.  Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions.

Authors:  R A Katz; C A Omer; J H Weis; S A Mitsialis; A J Faras; R V Guntaka
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

5.  Analysis of a bacterial hygromycin B resistance gene by transcriptional and translational fusions and by DNA sequencing.

Authors:  K R Kaster; S G Burgett; R N Rao; T D Ingolia
Journal:  Nucleic Acids Res       Date:  1983-10-11       Impact factor: 16.971

6.  Expression of the Rous sarcoma virus env gene from a simian virus 40 late-region replacement vector: effects of upstream initiation codons.

Authors:  L Perez; J W Wills; E Hunter
Journal:  J Virol       Date:  1987-04       Impact factor: 5.103

7.  Role of hemagglutinin cleavage and expression of M1 protein in replication of A/WS/33, A/PR/8/34, and WSN influenza viruses in mouse brain.

Authors:  R W Schlesinger; G L Bradshaw; F Barbone; M Reinacher; R Rott; P Husak
Journal:  J Virol       Date:  1989-04       Impact factor: 5.103

8.  Intracellular targeting and structural conservation of a prohormone-processing endoprotease.

Authors:  R S Fuller; A J Brake; J Thorner
Journal:  Science       Date:  1989-10-27       Impact factor: 47.728

9.  Preassembled capsids of type D retroviruses contain a signal sufficient for targeting specifically to the plasma membrane.

Authors:  S S Rhee; H X Hui; E Hunter
Journal:  J Virol       Date:  1990-08       Impact factor: 5.103

10.  Complete sequence of the Rous sarcoma virus env gene: identification of structural and functional regions of its product.

Authors:  E Hunter; E Hill; M Hardwick; A Bhown; D E Schwartz; R Tizard
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

View more
  36 in total

1.  A chimeric avian retrovirus containing the influenza virus hemagglutinin gene has an expanded host range.

Authors:  J Dong; M G Roth; E Hunter
Journal:  J Virol       Date:  1992-12       Impact factor: 5.103

2.  RNA dimerization defect in a Rous sarcoma virus matrix mutant.

Authors:  L J Parent; T M Cairns; J A Albert; C B Wilson; J W Wills; R C Craven
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  The Rous sarcoma virus Env glycoprotein contains a highly conserved motif homologous to tyrosine-based endocytosis signals and displays an unusual internalization phenotype.

Authors:  C Ochsenbauer; S R Dubay; E Hunter
Journal:  Mol Cell Biol       Date:  2000-01       Impact factor: 4.272

4.  A large region within the Rous sarcoma virus matrix protein is dispensable for budding and infectivity.

Authors:  T D Nelle; J W Wills
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

5.  Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

Authors:  R J Wool-Lewis; P Bates
Journal:  J Virol       Date:  1999-02       Impact factor: 5.103

6.  Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry.

Authors:  Zhaozhu Qiu; Susan T Hingley; Graham Simmons; Christopher Yu; Jayasri Das Sarma; Paul Bates; Susan R Weiss
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

7.  A substitution in rous sarcoma virus integrase that separates its two biologically relevant enzymatic activities.

Authors:  Wesley M Konsavage; Stephen Burkholder; Malgorzata Sudol; Amy L Harper; Michael Katzman
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

8.  Characterization of the proline-rich region of murine leukemia virus envelope protein.

Authors:  B Weimin Wu; P M Cannon; E M Gordon; F L Hall; W F Anderson
Journal:  J Virol       Date:  1998-07       Impact factor: 5.103

9.  Modifications in the binding domain of avian retrovirus envelope protein to redirect the host range of retroviral vectors.

Authors:  S Valsesia-Wittmann; A Drynda; G Deléage; M Aumailley; J M Heard; O Danos; G Verdier; F L Cosset
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

10.  Delayed cytopathicity of a feline leukemia virus variant is due to four mutations in the transmembrane protein gene.

Authors:  E Thomas; J Overbaugh
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.